Bio-Techne (TECH) EBITDA (2009 - 2026)

Bio-Techne's EBITDA history runs 18 years deep, the most recent figure standing at $46.5 million for Q1 2026.

• In Q1 2026, EBITDA rose 77.71% year-over-year to $46.5 million; the TTM figure through Mar 2026 stood at $124.8 million (changed 0.13% YoY), while the FY2025 annual figure was $91.8 million, down 41.08% from the prior year.
• EBITDA was $46.5 million for Q1 2026 at Bio-Techne, up from $40.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $83.0 million in Q2 2023 to a low of $4.5 million in Q2 2025.
• Historically, EBITDA has averaged $45.2 million across 5 years, with a median of $41.5 million in 2022.
• Biggest YoY gain for EBITDA was 329.51% in 2025; the steepest drop was 88.04% in 2025.
• A 5-year view of EBITDA shows it stood at $66.7 million in 2022, then plunged by 37.29% to $41.8 million in 2023, then slumped by 77.7% to $9.3 million in 2024, then soared by 329.51% to $40.1 million in 2025, then increased by 16.16% to $46.5 million in 2026.
• The last three EBITDA figures came in at $46.5 million (Q1 2026), $40.1 million (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.